Virgin Australia bondholders contesting the sale of the airline to private equity firm Bain Capital have blasted the airline’s administrators at Deloitte for failing to inform the court when applying for confidentiality orders that the bondholders had sought information on the terms of the deal.
Opal Tower owners’ corporation opts out of class action
Judge says FWC can hear dispute over stood down Qantas, Jetstar engineers
Border closure case pushed off as expert helps Victoria with second coronavirus wave
ACCC greenlights acquisition of Bayer’s animal health business
Decade-long dispute over vehicle parking monitoring patent rolls on
The race for the COVID-19 vaccine and patents: Do we need a temporary lockdown?
It is entirely possible that the first effective SARS-CoV-2 vaccine is developed in Australia, with an Australian firm securing patent rights to the vaccine. If that occurs, it is important to remember that a patent is not an impenetrable fortress. Patent laws already contain mechanisms to enable “special access” to patented pharmaceuticals and other technologies, including (perhaps especially) in times like this, say James Neil and Richard Hoad of Clayton Utz.